NO329746B1 - Anvendelse av metoksymorfolinodoksorubicin for behandling av levertumor og en farmasoytisk sammensetning inneholdende denne - Google Patents

Anvendelse av metoksymorfolinodoksorubicin for behandling av levertumor og en farmasoytisk sammensetning inneholdende denne Download PDF

Info

Publication number
NO329746B1
NO329746B1 NO20011116A NO20011116A NO329746B1 NO 329746 B1 NO329746 B1 NO 329746B1 NO 20011116 A NO20011116 A NO 20011116A NO 20011116 A NO20011116 A NO 20011116A NO 329746 B1 NO329746 B1 NO 329746B1
Authority
NO
Norway
Prior art keywords
liver
mmdx
mcg
use according
tumor
Prior art date
Application number
NO20011116A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011116L (no
NO20011116D0 (no
Inventor
Maria Adele Pacciarini
Olga Valota
David Kerr
Original Assignee
Nerviano Medical Sciences Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerviano Medical Sciences Srl filed Critical Nerviano Medical Sciences Srl
Publication of NO20011116D0 publication Critical patent/NO20011116D0/no
Publication of NO20011116L publication Critical patent/NO20011116L/no
Publication of NO329746B1 publication Critical patent/NO329746B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20011116A 1998-09-14 2001-03-05 Anvendelse av metoksymorfolinodoksorubicin for behandling av levertumor og en farmasoytisk sammensetning inneholdende denne NO329746B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9820012.4A GB9820012D0 (en) 1998-09-14 1998-09-14 Use of an anthracycline derivative for the treatment of a liver tumor
PCT/EP1999/006298 WO2000015203A2 (en) 1998-09-14 1999-08-27 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor

Publications (3)

Publication Number Publication Date
NO20011116D0 NO20011116D0 (no) 2001-03-05
NO20011116L NO20011116L (no) 2001-05-14
NO329746B1 true NO329746B1 (no) 2010-12-13

Family

ID=10838847

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011116A NO329746B1 (no) 1998-09-14 2001-03-05 Anvendelse av metoksymorfolinodoksorubicin for behandling av levertumor og en farmasoytisk sammensetning inneholdende denne

Country Status (25)

Country Link
EP (1) EP1112066B1 (de)
JP (2) JP5529360B2 (de)
KR (1) KR100685155B1 (de)
CN (1) CN1168452C (de)
AT (1) ATE245029T1 (de)
AU (1) AU773451B2 (de)
BR (1) BR9913627A (de)
CA (1) CA2343120C (de)
CZ (1) CZ295901B6 (de)
DE (1) DE69909636T2 (de)
DK (1) DK1112066T3 (de)
EA (1) EA004570B1 (de)
ES (1) ES2203175T3 (de)
GB (1) GB9820012D0 (de)
HU (1) HU229186B1 (de)
ID (1) ID28035A (de)
IL (2) IL141645A0 (de)
MY (1) MY124247A (de)
NO (1) NO329746B1 (de)
NZ (1) NZ510445A (de)
PL (1) PL198025B1 (de)
PT (1) PT1112066E (de)
TW (1) TWI222868B (de)
UA (1) UA69423C2 (de)
WO (1) WO2000015203A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
WO2004038404A2 (en) * 2002-10-28 2004-05-06 Pharmacia Italia Spa Method for optimizing therapeutic efficacy of nemorubicin
US20060264388A1 (en) * 2003-02-26 2006-11-23 Olga Valota Method for treating liver cancer by intrahepatic administration of nemorubicin
ES2552718T3 (es) * 2007-05-11 2015-12-01 Nerviano Medical Sciences S.R.L. Composición farmacéutica de una antraciclina
JP2016124818A (ja) * 2014-12-26 2016-07-11 日本化薬株式会社 転移性肝癌治療薬及び転移性肝癌の治療方法
PL244818B1 (pl) * 2021-11-03 2024-03-11 Urteste Spolka Z Ograniczona Odpowiedzialnoscia Związek-marker diagnostyczny raka wątroby, sposób wykrywania aktywności enzymatycznej, sposób diagnozowania raka wątroby, zestaw zawierający taki związek oraz związek do zastosowania medycznego

Also Published As

Publication number Publication date
NO20011116L (no) 2001-05-14
EP1112066B1 (de) 2003-07-16
JP2002524496A (ja) 2002-08-06
ATE245029T1 (de) 2003-08-15
EP1112066A2 (de) 2001-07-04
EA200100353A1 (ru) 2001-10-22
HUP0103557A2 (hu) 2002-01-28
TWI222868B (en) 2004-11-01
ID28035A (id) 2001-05-03
KR20010075074A (ko) 2001-08-09
HUP0103557A3 (en) 2002-12-28
EA004570B1 (ru) 2004-06-24
CA2343120A1 (en) 2000-03-23
IL141645A0 (en) 2002-03-10
JP2014088398A (ja) 2014-05-15
CZ2001895A3 (cs) 2001-08-15
PT1112066E (pt) 2003-11-28
IL141645A (en) 2007-05-15
KR100685155B1 (ko) 2007-02-22
NZ510445A (en) 2003-01-31
GB9820012D0 (en) 1998-11-04
NO20011116D0 (no) 2001-03-05
HK1050853A1 (en) 2003-07-11
DK1112066T3 (da) 2003-11-03
WO2000015203A3 (en) 2000-07-20
JP5529360B2 (ja) 2014-06-25
BR9913627A (pt) 2001-05-22
DE69909636T2 (de) 2004-06-09
PL348749A1 (en) 2002-06-03
UA69423C2 (uk) 2004-09-15
CA2343120C (en) 2009-11-24
AU773451B2 (en) 2004-05-27
CN1383382A (zh) 2002-12-04
CN1168452C (zh) 2004-09-29
PL198025B1 (pl) 2008-05-30
ES2203175T3 (es) 2004-04-01
AU5742199A (en) 2000-04-03
DE69909636D1 (de) 2003-08-21
WO2000015203A2 (en) 2000-03-23
CZ295901B6 (cs) 2005-11-16
MY124247A (en) 2006-06-30
HU229186B1 (en) 2013-09-30

Similar Documents

Publication Publication Date Title
EP1323423B1 (de) Kombinationspräparat enthaltend ein Morpholinyl Anthracyclinderivat und einen Topoisomerase II Inhibitor
US9358247B2 (en) Methods and compositions for promoting activity of anti-cancer therapies
TW201004619A (en) Methods and compositions for therapeutic treatment
CN103505468B (zh) 曲札茋苷在制备改善微循环障碍药物中的应用
JP2014088398A (ja) 肝臓腫瘍治療へのアントラサイクリン誘導体の使用
MXPA04010853A (es) Derivado de epotilona para el tratamiento de hepatoma y otras enfermedades de cancer.
CN101279967B (zh) 一种治疗癌症的三甲基呫吨酮-4-乙酸药物组合物及其用途
EP1596874B1 (de) Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin
CN100482224C (zh) 一种治疗肿瘤的组合药物及其应用
CN102688489A (zh) 含有雷公藤甲素及雷公藤甲素类衍生物和Bcl-2抑制剂的药物组合物及其应用
CN112891558A (zh) 一种尼达尼布超分子共载包合物
CN120154734A (zh) 维奈克拉联合瑞戈非尼在治疗急性髓系白血病中的应用

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees